Aila Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Latest Deal Amount
  • $10.7M

  • Investors
  • 4

Aila Biotech General Information

Description

Developer of a gene delivery technology designed to improve clinical treatment of neuroinflammatory conditions. The company's technology produces immune-regulating biologics at the disease site, controls biological expression and manages treatment effects effectively, enabling healthcare providers to prevent neuroinflammatory damage and pathology progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • The Round House, Newmarket Road
  • Cambridge CB2 8PB
  • England, United Kingdom
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Corporate Office
  • The Round House, Newmarket Road
  • Cambridge CB2 8PB
  • England, United Kingdom

Aila Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aila Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 01-Oct-2026 $10.7M In Progress Startup
4. Accelerator/Incubator 01-May-2025 Completed Startup
3. Accelerator/Incubator 16-May-2023 Completed Startup
2. Accelerator/Incubator 28-May-2026 $30K $30K Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view Aila Biotech’s complete valuation and funding history, request access »

Aila Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aila Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Founders at the University of Cambridge Accelerator/Incubator
University of Toronto University
Accelerate@Babraham Accelerator/Incubator
University of Cambridge University
To view Aila Biotech’s complete investors history, request access »

Aila Biotech FAQs

  • When was Aila Biotech founded?

    Aila Biotech was founded in 2021.

  • Where is Aila Biotech headquartered?

    Aila Biotech is headquartered in Cambridge, United Kingdom.

  • What is the size of Aila Biotech?

    Aila Biotech has 4 total employees.

  • What industry is Aila Biotech in?

    Aila Biotech’s primary industry is Drug Delivery.

  • Is Aila Biotech a private or public company?

    Aila Biotech is a Private company.

  • What is the current valuation of Aila Biotech?

    The current valuation of Aila Biotech is .

  • What is Aila Biotech’s current revenue?

    The current revenue for Aila Biotech is .

  • How much funding has Aila Biotech raised over time?

    Aila Biotech has raised $42.5K.

  • Who are Aila Biotech’s investors?

    Founders at the University of Cambridge, University of Toronto, Accelerate@Babraham, and University of Cambridge have invested in Aila Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process